Investors Overview

Investors Overview

Our Mission

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

Learn more about BD

News Releases

11/24/2020

Summary Toggle BD Board Increases Dividend

FRANKLIN LAKES, N.J. , Nov. 24, 2020 /PRNewswire/ -- The Board of Directors of BD ( Becton, Dickinson and Company ) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, an increase of 5.1% from the previous quarter. The dividend will be payable on December 31, 2020 to holders

PDF Version
11/23/2020

Summary Toggle BD Announces Streamlined Reporting Capabilities for COVID-19 Data

Reports Generated by BD Synapsys™ 3.84 Informatics Solution Simplify Mandatory Public Health Reporting FRANKLIN LAKES, N.J. , Nov. 23, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for

PDF Version
11/19/2020

Summary Toggle BD to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference

FRANKLIN LAKES, N.J. , Nov. 19, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 3 rd Annual HealthCONx Virtual Conference on Wednesday, December 2, 2020 , at 8:00 a.m. ET .

PDF Version
11/12/2020

Summary Toggle BD Acquires the Medical Business Assets of CUBEX LLC, Broadening Automated Dispensing Portfolio Across Care Continuum

FRANKLIN LAKES, N.J. , Nov. 12, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, announced today it has acquired the Medical Business assets of CUBEX LLC , which is a privately-held company that develops cloud-based software

PDF Version
11/10/2020

Summary Toggle BD Announces Canadian Government Order of More Than 7 Million Portable, Rapid Point-of-Care Antigen Tests to Detect SARS-CoV-2 in 15 minutes

MISSISSAUGA, ON , Nov. 10, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been authorized for use by Health Canada under

PDF Version
11/09/2020

Summary Toggle BD to Present at Investor Virtual Healthcare Conferences

FRANKLIN LAKES, N.J. , Nov. 9, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming virtual healthcare conferences: Stifel 2020 Virtual Healthcare Conference November 16,

PDF Version